BioGram ApS: Financial statements 2022
CVR: 40922598
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioGram ApS (CVR 40922598) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 51,785 and a net result of DKK 102,704 compared with DKK 182,003 the year before. That is a decrease of 77.7% compared with the year before. Equity in the 2022 report amounted to DKK 255,843. The solvency ratio was 83.3%.
- Gross Profit
- DKK 51,785
- Profit/Loss
- DKK 102,704
- Equity
- DKK 255,843
- Total Assets
- DKK 307,071
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 52 t. | 103 t. | 256 t. | - |
| 2021 | - | 233 t. | 182 t. | 452 t. | - |
Keep an eye on BioGram ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioGram ApS has published its annual report for 2021. Gross profit came to DKK 232,579, and the net result was DKK 182,003.
About BioGram ApS
BioGram ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2019. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Per Gram. The company is owned by BioGram Holding ApS. In 2025, the company reported a gross profit of DKK 287,937 and a net result of DKK 222,179 compared with DKK 170,237 the year before. Equity in the 2025 report amounted to DKK 127,799.